Abstract
This review describes the strategy for the development of multifunctional dendrimeric and hyperbranched polymers, collectively named dendritic polymers, aiming at their application as drug and gene delivery systems. Employing well-characterized and mainly commercially available dendritic polymers, the functionalization of these polymers is aimed at providing drug carriers of low toxicity, high encapsulating capacity, specificity to certain type of cells and transport ability through their membranes. Following a step-wise functionalization strategy of the starting dendritic polymers one has the option to prepare products that fulfill one or more of these requirements. In particular, in addition to polyvalency which is a common feature of the dendritic polymers, these carriers bearing a number of targeting ligands exhibit specificity to certain cells, another type of groups secures stability in biological milieu and prolonged circulation, while other moieties facilitate their transport through cell membranes. Furthermore, dendritic polymers applied for gene delivery should be or become cationic in the biological environment for the formation of complexes with the negatively charged genetic material.
Keywords: Dendrimers, hyperbranched polymers, dendritic polymers, nanocarriers, drug delivery system, gene delivery
Current Topics in Medicinal Chemistry
Title: Multifunctional Dendritic Drug Delivery Systems: Design, Synthesis, Controlled and Triggered Release
Volume: 8 Issue: 14
Author(s): Constantinos M. Paleos, Dimitris Tsiourvas, Zili Sideratou and Leto Tziveleka
Affiliation:
Keywords: Dendrimers, hyperbranched polymers, dendritic polymers, nanocarriers, drug delivery system, gene delivery
Abstract: This review describes the strategy for the development of multifunctional dendrimeric and hyperbranched polymers, collectively named dendritic polymers, aiming at their application as drug and gene delivery systems. Employing well-characterized and mainly commercially available dendritic polymers, the functionalization of these polymers is aimed at providing drug carriers of low toxicity, high encapsulating capacity, specificity to certain type of cells and transport ability through their membranes. Following a step-wise functionalization strategy of the starting dendritic polymers one has the option to prepare products that fulfill one or more of these requirements. In particular, in addition to polyvalency which is a common feature of the dendritic polymers, these carriers bearing a number of targeting ligands exhibit specificity to certain cells, another type of groups secures stability in biological milieu and prolonged circulation, while other moieties facilitate their transport through cell membranes. Furthermore, dendritic polymers applied for gene delivery should be or become cationic in the biological environment for the formation of complexes with the negatively charged genetic material.
Export Options
About this article
Cite this article as:
Paleos M. Constantinos, Tsiourvas Dimitris, Sideratou Zili and Tziveleka Leto, Multifunctional Dendritic Drug Delivery Systems: Design, Synthesis, Controlled and Triggered Release, Current Topics in Medicinal Chemistry 2008; 8 (14) . https://dx.doi.org/10.2174/156802608785848996
DOI https://dx.doi.org/10.2174/156802608785848996 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Inhibitors of HDACs - Effective Drugs Against Cancer?
Current Cancer Drug Targets Atypical GTPases as Drug Targets
Anti-Cancer Agents in Medicinal Chemistry The Role of Autophagy: What can be Learned from the Genetic Forms of Amyotrophic Lateral Sclerosis
CNS & Neurological Disorders - Drug Targets The Application of Photofrin II® as a Sensitizing Agent for Ionizing Radiation-A New Approach in Tumor Therapy?
Current Medicinal Chemistry Integrins: Regulators of Tissue Function and Cancer Progression
Current Pharmaceutical Design Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance
Anti-Cancer Agents in Medicinal Chemistry Unorthodox Inhibitors of HIV Protease: Looking Beyond Active-site-directed Peptidomimetics
Current Pharmaceutical Design Mesenchymal Stromal Cells from Umbilical Cord Blood
Current Stem Cell Research & Therapy Oncolytic Viruses for Induction of Anti-Tumor Immunity
Current Pharmaceutical Biotechnology Posttranscriptional Regulation of p53 and its Targets by RNABinding Proteins
Current Molecular Medicine Malignant Phyllodes Tumors with Heterologous Sarcomatous Elements Presenting as Hyperechoic Masses on Ultrasonography: A Case Report
Current Medical Imaging Adrenomedullin and Nitric Oxide: Implications for the Etiology and Treatment of Primary Brain Tumors
CNS & Neurological Disorders - Drug Targets Retinoic Acid Metabolism and Mechanism of Action: A Review
Current Drug Metabolism Targeting Angiogenesis in Soft Tissue Sarcomas
Current Angiogenesis (Discontinued) Targeted – Therapy and Imaging Response: A New Paradigm For Clinical Evaluation?
Reviews on Recent Clinical Trials Ganoderma lucidum (Ling-zhi): The Impact of Chemistry on Biological Activity in Cancer
Current Bioactive Compounds Immunomodulatory Activity of Garlic
Current Immunology Reviews (Discontinued) Parthenogenetic Cell Lines: An Unstable Equilibrium Between Pluripotency and Malignant Transformation
Current Pharmaceutical Biotechnology Acridine Orange is an Effective Anti-Cancer Drug that Affects Mitochondrial Function in Osteosarcoma Cells
Current Pharmaceutical Design Staurosporine Analogues from Microbial and Synthetic Sources and Their Biological Activities
Current Medicinal Chemistry